8SL7
Butyricicoccus sp. BIOML-A1 tryptophanase complex with (3S) ALG-05
8SL7 の概要
| エントリーDOI | 10.2210/pdb8sl7/pdb |
| 分子名称 | Tryptophanase, (E)-3-[(3S)-3-chloro-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-L-alanine (3 entities in total) |
| 機能のキーワード | tryptophan-indole lyase, tryptophananse, plp-dependent enzyme, inhibitor-bound complex, lyase |
| 由来する生物種 | Butyricicoccus sp. BIOML-A1 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 260638.62 |
| 構造登録者 | |
| 主引用文献 | Graboski, A.L.,Kowalewski, M.E.,Simpson, J.B.,Cao, X.,Ha, M.,Zhang, J.,Walton, W.G.,Flaherty, D.P.,Redinbo, M.R. Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate. Cell Chem Biol, 30:1402-1413.e7, 2023 Cited by PubMed Abstract: Indoxyl sulfate is a microbially derived uremic toxin that accumulates in late-stage chronic kidney disease and contributes to both renal and cardiovascular toxicity. Indoxyl sulfate is generated by the metabolism of indole, a compound created solely by gut microbial tryptophanases. Here, we characterize the landscape of tryptophanase enzymes in the human gut microbiome and find remarkable structural and functional similarities across diverse taxa. We leverage this homology through a medicinal chemistry campaign to create a potent pan-inhibitor, (3S) ALG-05, and validate its action as a transition-state analog. (3S) ALG-05 successfully reduces indole production in microbial culture and displays minimal toxicity against microbial and mammalian cells. Mice treated with (3S) ALG-05 show reduced cecal indole and serum indoxyl sulfate levels with minimal changes in other tryptophan-metabolizing pathways. These studies present a non-bactericidal pan-inhibitor of gut microbial tryptophanases with potential promise for reducing indoxyl sulfate in chronic kidney disease. PubMed: 37633277DOI: 10.1016/j.chembiol.2023.07.015 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.07 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






